Literature DB >> 7629136

Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding.

B Z Peterson1, W A Catterall.   

Abstract

The pore-forming alpha 1 subunit of L-type voltage-gated Ca2+ channels contains a Ca(2+)-binding site that is allosterically coupled to the receptor site for dihydropyridine (DHP) Ca2+ antagonists. Site-directed mutations of conserved Phe and Glu residues in the pore-lining SS1/SS2 segments greatly reduced Ca2+ enhancement of DHP binding. Substitution of Phe-1013 in the alpha 1 subunit from rabbit skeletal muscle (alpha 1S) with Gly (F1013G) as in DHP-insensitive Ca2+ channels caused a 4-fold decrease in sensitivity to Ca2+. Mutation of the Ca(2+)-binding residues Glu-1014 in domain III and Glu-1323 in domain IV to Gln (E1014Q and E1323Q) caused 11- and 35-fold decreases in sensitivity to Ca2+, respectively, as well as decreases in the maximal DHP binding affinities attained at optimal concentrations of Ca2+. DHP binding to the charge-reversal mutation, E1014K, had no sensitivity to Ca2+. Our results demonstrate that high affinity Ca2+ binding to the Glu residues in the SS1/SS2 segments of domains III and IV of alpha 1S stabilizes the DHP receptor site in its high affinity state. We propose a three-state model in which the affinity for DHPs is dependent on the presence of 0, 1, or 2 bound Ca2+ ions at sites in the pore.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629136     DOI: 10.1074/jbc.270.31.18201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The [beta]2a subunit is a molecular groom for the Ca2+ channel inactivation gate.

Authors:  S Restituito; T Cens; C Barrere; S Geib; S Galas; M De Waard; P Charnet
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  Calcium inhibits dihydropyridine-stimulated increases in opening and unitary conductance of a plant Ca²+ channel.

Authors:  Miguel A Piñeros; Mark Tester
Journal:  J Membr Biol       Date:  2011-01-28       Impact factor: 1.843

3.  A new view of K+ -induced contraction in rat aorta: the role of Ca2+ binding.

Authors:  Gennadi M Kravtsov; Iain C Bruce; Tak Ming Wong; Chiu-Yin Kwan
Journal:  Pflugers Arch       Date:  2003-06-25       Impact factor: 3.657

4.  Multiple loops of the dihydropyridine receptor pore subunit are required for full-scale excitation-contraction coupling in skeletal muscle.

Authors:  Leah Carbonneau; Dipankar Bhattacharya; David C Sheridan; Roberto Coronado
Journal:  Biophys J       Date:  2005-04-22       Impact factor: 4.033

Review 5.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

6.  Effect of nifedipine on depolarization-induced force responses in skinned skeletal muscle fibres of rat and toad.

Authors:  G S Posterino; G D Lamb
Journal:  J Muscle Res Cell Motil       Date:  1998-01       Impact factor: 2.698

7.  A skeletal muscle L-type Ca2+ channel with a mutation in the selectivity filter (CaV1.1 E1014K) conducts K<sup/>.

Authors:  Donald Beqollari; Karen Dockstader; Roger A Bannister
Journal:  J Biol Chem       Date:  2018-01-11       Impact factor: 5.157

8.  Cch1 mediates calcium entry in Cryptococcus neoformans and is essential in low-calcium environments.

Authors:  Min Liu; Ping Du; Garrett Heinrich; Gary M Cox; Angie Gelli
Journal:  Eukaryot Cell       Date:  2006-09-01

9.  Conformational changes induced in voltage-gated calcium channel Cav1.2 by BayK 8644 or FPL64176 modify the kinetics of secretion independently of Ca2+ influx.

Authors:  Merav Marom; Yamit Hagalili; Ariel Sebag; Lior Tzvier; Daphne Atlas
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 10.  Molecular pharmacology of high voltage-activated calcium channels.

Authors:  Clinton J Doering; Gerald W Zamponi
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.